Prostate cancer (PC) has become the most commonly diagnosed cancer in the male and the second-most common cause of cancer-related death in men, surpassed only by lung cancer. Patients with PC are usually asymptomatic in early stages; however, blood in the urine, bony pains, or voiding difficulties can be present in advanced stages.
The decision to do a prostate biopsy depends on PSA test, positive family history, as well as the rectal exam. A transrectal ultrasound and biopsy of the prostate usually establish the diagnosis.
Because of the recent controversy about PSA screening, we found it necessary for the Wichita Urology Group to clarify a few points about PSA testing. PSA has undeniably contributed to a decrease in mortality and morbidity of prostate cancer. There are certain situations whereby PSA screening is not recommended and may even expose patients to unnecessary risks. After reviewing the published data and the guidelines on PSA screening, we recommend screening in the following cases:
- Men age 40 or older with increased risk of prostate cancer, namely African Americans and those with family history of prostate cancer
- All men between the ages of 54 and 69 (this group benefits the most from PSA screening)
- Men above age 70 with greater than 10 year’s life expectancy
- All men who have an abnormal rectal exam
- Men older than 60 with PSA < 1.0 can have the screening at longer intervals
- Men with Lower Urinary Tract Symptoms (LUTS) who have life expectancy greater than 10 years and if the diagnosis of prostate cancer can modify the management
We realize that the decision to screen in certain situations can be challenging and for that reason Wichita Urology Group doctors are always available to provide expert advice for your patients.